- Investing Ideas
- /
- U.S. High Growth Potential Companies
U.S. High Growth Potential Companies
Results
1507
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
1,507 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
VAC | US$85.38 | -6.1% | -9.6% | US$3.0b | US$105.00 | PE14.7x | E23.7% | 3.7% | Consumer Services | ||
EQT | US$48.79 | -10.0% | 33.4% | US$29.2b | US$53.85 | PE126.4x | E33.1% | 1.3% | Energy | ||
MMI | US$38.95 | 0.9% | 7.8% | US$1.5b | US$30.00 | PS2.2x | E139.8% | 1.3% | Real Estate Management and Development | ||
HAE | US$64.93 | 2.0% | -13.3% | US$3.3b | US$96.80 | PE25.1x | E21.1% | n/a | Healthcare | ||
VSTA | US$2.92 | 4.7% | -23.5% | US$228.5m | US$2.69 | PS0.9x | E119.5% | n/a | Consumer Services | ||
SCYX | US$1.02 | -8.1% | -40.0% | US$38.3m | US$6.67 | PS4.5x | E27.5% | n/a | Pharmaceuticals & Biotech | ||
MLAB | US$144.50 | -3.8% | 34.8% | US$784.4m | US$150.00 | PS3.3x | E121.2% | 0.4% | Pharmaceuticals & Biotech | ||
VTOL | US$34.81 | -4.9% | 28.6% | US$1.0b | US$48.50 | PE18.1x | E33.8% | n/a | Energy | ||
GDYN | US$19.90 | -7.7% | 42.6% | US$1.7b | US$26.00 | PE411.7x | E43.8% | n/a | Software | ||
GENI | US$8.77 | -9.1% | 27.5% | US$1.9b | US$11.54 | PS4.4x | E71.8% | n/a | Consumer Services | ||
FLYW | US$11.05 | -41.9% | -61.7% | US$2.2b | US$18.31 | PE472.7x | E62.6% | n/a | Diversified Financials | ||
RVSB | US$5.14 | -1.9% | 11.4% | US$108.6m | US$6.25 | PB0.7x | E59.7% | 1.6% | Banks | ||
EGBN | US$22.76 | -7.6% | -1.4% | US$701.0m | US$27.67 | PB0.6x | E101.2% | 2.9% | Banks | ||
SHAK | US$110.15 | -1.0% | 6.6% | US$4.7b | US$136.50 | PE432.6x | E32.3% | n/a | Consumer Services | ||
ACA | US$93.37 | -5.3% | 14.2% | US$4.5b | US$117.67 | PE35.6x | E35.2% | 0.2% | Capital Goods | ||
CHCT | US$18.27 | -1.5% | -32.4% | US$522.6m | US$22.00 | PB1.1x | E39.9% | 10.2% | Real Estate | ||
AVAV | US$153.65 | -3.3% | 21.4% | US$4.2b | US$226.74 | PE88.5x | E39.3% | n/a | Capital Goods | ||
PNTG | US$25.50 | -5.5% | 51.1% | US$885.2m | US$36.00 | PE41.4x | E23.8% | n/a | Healthcare | ||
BTMD | US$4.32 | -11.8% | -26.7% | US$159.9m | US$9.87 | PE18.7x | E69.0% | n/a | Pharmaceuticals & Biotech | ||
PERF | US$1.91 | -20.4% | -23.9% | US$196.6m | US$3.90 | PE38.7x | E20.4% | n/a | Software | ||
SRAD | US$21.48 | -4.5% | 120.3% | US$6.1b | US$21.73 | PE103.6x | E29.9% | n/a | Consumer Services | ||
VMD | US$7.90 | -2.5% | -7.1% | US$303.7m | US$12.83 | PE29.5x | E32.5% | n/a | Healthcare | ||
SLQT | US$4.59 | -21.1% | 157.9% | US$741.9m | US$7.33 | PS0.5x | E185.1% | n/a | Insurance | ||
MPB | US$28.43 | -4.4% | 39.7% | US$555.2m | US$36.50 | PB1x | E21.4% | 2.8% | Banks |